PTSD

>

Latest News

Reagan Udall Foundation for FDA Facilitates Discussion on Urgent Needs in PTSD Therapy
Reagan Udall Foundation for FDA Facilitates Discussion on Urgent Needs in PTSD Therapy

September 6th 2024

The Reagan Udall Foundation hosted a meeting on PTSD treatment needs, with experts and stakeholders highlighting gaps and potential therapies, including MDMA-assisted therapy.

Phase 1b Trial Signals Benefit of VLS-01 for Treatment-Resistant Depression | Image Credit: Nik Shuliahin/Unsplash
Phase 1b Trial Signals Benefit of VLS-01 for Treatment-Resistant Depression

August 13th 2024

MDMA-Assisted Therapy Trial Participant Reacts to FDA’s Decision on Lykos’ NDA
MDMA-Assisted Therapy Trial Participant Reacts to FDA’s Decision on Lykos’ NDA

August 12th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Rejects Application for MDMA-Assisted Therapy in PTSD, Calls for Additional Trial

August 9th 2024

Targeted Memory Reactivation Enhances PTSD Treatment Effectiveness
Targeted Memory Reactivation Enhances PTSD Treatment Effectiveness

August 7th 2024

More News

Hearing Voices Linked to PTSD and Dissociation

Hearing Voices Linked to PTSD and Dissociation

October 16th 2023

Participants with PTSD in a new study heard voices more significantly than did patients with schizophrenia and schizoaffective disorder, according to investigators.

Trauma-Focused Psychotherapy Effective in Adults with PTSD Despite Sleep Disturbances

Trauma-Focused Psychotherapy Effective in Adults with PTSD Despite Sleep Disturbances

July 12th 2023

Investigators systematically review data to further understand the relationship between sleep and PTSD as it impacts treatment outcomes.

<12
© 2024 MJH Life Sciences

All rights reserved.